Hikma Pharmaceuticals PLC (HKMPY)
OTCMKTS
· Delayed Price · Currency is USD
56.20
-0.71 (-1.25%)
Jun 18, 2025, 3:45 PM EDT
Hikma Pharmaceuticals Market Cap
Hikma Pharmaceuticals has a market cap or net worth of $6.08 billion as of June 18, 2025. Its market cap has increased by 10.57% in one year.
Market Cap
6.08B
Enterprise Value
7.27B
Revenue
3.13B
Ranking
n/a
PE Ratio
16.95
Stock Price
$56.20
Market Cap Chart
Since November 2, 2005, Hikma Pharmaceuticals's market cap has increased from 833.84M to 6.08B, an increase of 629.62%. That is a compound annual growth rate of 10.65%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.60B |
| Elite Pharmaceuticals | 827.80M |
| Veradigm | 747.25M |
| Nika Pharmaceuticals | 708.22M |
| Tian'an Technology Group | 637.25M |
| CytoDyn | 437.04M |
| American Oncology Network | 408.69M |
| Glass House Brands | 398.13M |